Definitions for "Trastuzumab"
A biologic therapy used to treat metastatic breast cancer in patients whose cancers are positive for the human epidermal growth factor-2 (HER-2).
Generic name for Herceptin
(tras-TOO-zuh-mab) A monoclonal antibody used to treat breast cancer that is estrogen-receptor positive and has spread after treatment with other drugs. It is also being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Trastuzumab binds to HER-2, a human epidermal growth factor receptor, and can kill HER-2 positive cancer cells. Also called Herceptin.